Expanding the spectrum of tyrosine kinase fusions in calcified chondroid mesenchymal neoplasms: Identification of a novel PDGFRA::USP8 gene fusion.
Yael FisherMaribel D LacambraShahd S AlmohsenChit ChowJason L HornickKa-Fai ToBrendan C DicksonPublished in: Genes, chromosomes & cancer (2023)
Calcified chondroid mesenchymal neoplasms represent a distinct, and recently recognized, spectrum of tumors. To date most cases have been reported to be characterized by FN1 gene fusions involving multiple potential tyrosine kinase partners. Following incidental identification of a tumor morphologically corresponding to calcified chondroid mesenchymal neoplasm, but with a PDGFRA::USP8 gene fusion, we undertook a retrospective review to identify and characterize additional such cases. A total of four tumors were identified. Each was multilobulated and composed of polygonal-epithelioid-stellate cells with a background of chondroid matrix containing distinctive patterns of calcification. Targeted RNA sequencing revealed an identical PDGFRA (exon 22)::USP8 (exon 5) gene fusion in each case. Subsequent immunohistochemical staining confirmed the presence of PDGFRα overexpression. In summary, we report a series of four tumors within the morphologic spectrum of calcified chondroid mesenchymal neoplasms. In contrast to prior reports, these tumors harbored a novel PDGFRA::USP8 gene fusion, rather than FN1 rearrangement. Our findings expand the molecular diversity of these neoplasms, and suggest they are united through activation of protein kinases.
Keyphrases
- tyrosine kinase
- copy number
- stem cells
- genome wide
- bone marrow
- epidermal growth factor receptor
- genome wide identification
- induced apoptosis
- magnetic resonance
- cell proliferation
- chronic kidney disease
- risk assessment
- signaling pathway
- climate change
- drug delivery
- hepatitis c virus
- human immunodeficiency virus
- adverse drug